STOCK TITAN

CFTR-PA Financials

CFTR-PA
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows CFTR-PA (CFTR-PA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CFTR-PA FY2025

An asset-heavy balance sheet generates cash, but leverage and shareholder payouts keep profits and liquidity from compounding.

From FY2023 through FY2025, operating cash flow held in a relatively narrow band of $20.9M to $30.3M even while net losses persisted, because annual depreciation of roughly $36M to $37M was larger than the loss. That says the asset base is producing cash before financing, but much of that benefit is absorbed by an interest burden that reached $28.3M in FY2025.

The capital structure is more demanding than the bottom line alone suggests: FY2025 carried $1.14B of assets against only $170.0M of equity, and debt-to-equity remained above 3x after nearly 4x in FY2024. With that smaller equity cushion, even modest changes in asset cash yield can swing equity returns sharply.

Cash generation is not translating into a larger cash reserve. In FY2025, operating cash flow of $27.4M was well below buybacks and dividends of $53.6M, helping explain why cash fell to $25.4M from $36.1M despite positive operations. The business is sending out a meaningful share of internally generated cash rather than retaining it.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score pending refresh

We are recalculating CFTR-PA's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial
5/6

CFTR-PA passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
-3.25x

For every $1 of reported earnings, CFTR-PA generates $-3.25 in operating cash flow ($27.4M OCF vs -$8.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$97.9M
YoY+2.4%
5Y CAGR+44.2%

CFTR-PA generated $97.9M in revenue in fiscal year 2025. This represents an increase of 2.4% from the prior year.

EBITDA
N/A
Net Income
-$8.4M
YoY+7.9%

CFTR-PA reported -$8.4M in net income in fiscal year 2025. This represents an increase of 7.9% from the prior year.

EPS (Diluted)
$-0.70
YoY-6.1%

CFTR-PA earned $-0.70 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 6.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$25.4M
YoY-29.7%
5Y CAGR-5.4%

CFTR-PA held $25.4M in cash against $600.7M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
11M
YoY-11.9%

CFTR-PA had 11M shares outstanding in fiscal year 2025. This represents a decrease of 11.9% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
-8.6%
YoY+1.0pp
5Y CAGR-19.8pp

CFTR-PA's net profit margin was -8.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.0 percentage points from the prior year.

Return on Equity
-5.0%
YoY-0.9pp
5Y CAGR-6.2pp

CFTR-PA's ROE was -5.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.9 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$40.4M
YoY-32.3%
5Y CAGR+54.8%

CFTR-PA spent $40.4M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 32.3% from the prior year.

Capital Expenditures
N/A

CFTR-PA Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $26.6M+7.2% $24.8M+1.5% $24.4M-2.2% $25.0M+5.4% $23.7M+2.2% $23.2M-1.2% $23.4M-9.1% $25.8M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $991K+306.5% $244K-25.7% $328K+340.4% $75K+0.7% $74K-32.0% $109K+60.4% $68K+7.3% $63K
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $6.8M-0.9% $6.9M-5.7% $7.3M+2.1% $7.2M+3.7% $6.9M-0.7% $7.0M-2.0% $7.1M+5.0% $6.8M
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income -$2.5M+50.3% -$5.1M-326.4% -$1.2M+31.1% -$1.7M-283.5% -$449K+90.6% -$4.8M-104.5% -$2.3M-19.1% -$2.0M
EPS (Diluted) $-0.22 N/A $-0.10+28.6% $-0.14-250.0% $-0.04 N/A $-0.17-21.4% $-0.14

CFTR-PA Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $1.1B-1.2% $1.1B-1.2% $1.2B-0.8% $1.2B-0.2% $1.2B+3.2% $1.1B-1.9% $1.1B+3.0% $1.1B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $23.5M-7.5% $25.4M-14.5% $29.7M+4.2% $28.5M+22.4% $23.3M-35.6% $36.1M+29.3% $27.9M+9.7% $25.5M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $968.1M+0.1% $966.8M+0.6% $961.3M+0.7% $955.0M+0.9% $946.5M+5.2% $899.5M-1.1% $909.8M+6.2% $856.4M
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt $602.6M+0.3% $600.7M-1.8% $611.7M+1.7% $601.7M+2.3% $588.2M N/A N/A N/A
Total Equity $154.7M-9.0% $170.0M-10.3% $189.5M-7.5% $204.9M-5.1% $215.8M-4.7% $226.5M-4.8% $238.0M-7.6% $257.7M
Retained Earnings -$147.3M-3.7% -$142.0M-6.7% -$133.1M-4.5% -$127.3M-5.3% -$120.9M-4.5% -$115.7M-9.2% -$105.9M-7.6% -$98.4M

CFTR-PA Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$6.0M-202.8% $5.8M+5.3% $5.5M-24.1% $7.3M-15.5% $8.7M-5.8% $9.2M+29.6% $7.1M-23.4% $9.2M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow $890K+300.0% -$445K+73.6% -$1.7M+31.1% -$2.4M+61.4% -$6.3M-136.5% $17.4M+1310.4% -$1.4M-126.2% $5.5M
Financing Cash Flow $3.1M+132.0% -$9.6M-66.1% -$5.8M-4479.8% $132K+100.9% -$14.1M+22.2% -$18.1M-348.0% -$4.1M+76.6% -$17.3M
Dividends Paid $1.9M-40.1% $3.2M-4.3% $3.3M-1.8% $3.4M+0.5% $3.4M-5.1% $3.5M-4.6% $3.7M-6.4% $4.0M
Share Buybacks $11.2M-2.7% $11.5M-5.4% $12.1M+61.7% $7.5M-19.1% $9.3M-29.9% $13.2M-9.7% $14.6M-6.2% $15.6M

CFTR-PA Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin -9.5%+10.9pp -20.4%-15.5pp -4.9%+2.0pp -6.9%-5.0pp -1.9%+18.7pp -20.6%-10.6pp -9.9%-2.4pp -7.6%
Return on Equity -1.6%+1.3pp -3.0%-2.3pp -0.6%+0.2pp -0.8%-0.6pp -0.2%+1.9pp -2.1%-1.1pp -1.0%-0.2pp -0.8%
Return on Assets -0.2%+0.2pp -0.4%-0.3pp -0.1%+0.1pp -0.1%-0.1pp -0.0%+0.4pp -0.4%-0.2pp -0.2%-0.0pp -0.2%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 3.89+0.4 3.53+0.3 3.23+0.3 2.94+0.2 2.73-1.2 3.97+0.1 3.82+0.5 3.32
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Frequently Asked Questions

CFTR-PA (CFTR-PA) reported $97.9M in total revenue for fiscal year 2025. This represents a 2.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

CFTR-PA (CFTR-PA) revenue grew by 2.4% year-over-year, from $95.5M to $97.9M in fiscal year 2025.

No, CFTR-PA (CFTR-PA) reported a net income of -$8.4M in fiscal year 2025, with a net profit margin of -8.6%.

CFTR-PA (CFTR-PA) reported diluted earnings per share of $-0.70 for fiscal year 2025. This represents a -6.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, CFTR-PA (CFTR-PA) had $25.4M in cash and equivalents against $600.7M in long-term debt.

CFTR-PA (CFTR-PA) had a net profit margin of -8.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

CFTR-PA (CFTR-PA) has a return on equity of -5.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

CFTR-PA (CFTR-PA) generated $27.4M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

CFTR-PA (CFTR-PA) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, CFTR-PA (CFTR-PA) spent $40.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

CFTR-PA (CFTR-PA) had 11M shares outstanding as of fiscal year 2025.

CFTR-PA (CFTR-PA) had a debt-to-equity ratio of 3.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

CFTR-PA (CFTR-PA) had a return on assets of -0.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

CFTR-PA (CFTR-PA) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

CFTR-PA (CFTR-PA) has an earnings quality ratio of -3.25x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top